This study is comparing Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) with placebo for people with Treatment-resistant Depression in bipolarity. Participants receive Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) or placebo and complete study visits and assessments.
In Houston
Why is this study shown?
This study is directly about Depression.
Depression, BipolarityBiologicalFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
This observational study is following people with Treatment Resistant Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Response to ketamine in with treatment-resistant depression or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In Slovakia
Why is this study shown?
This study is directly about Depression.
DepressionOtherFrom 18 Years to 65 Years
Countries
Slovakia
Sponsor
Department of Psychiatry of Faculty of Medicine, Comenius University and University Hospital Bratislava
This observational study is following people with Treatment Resistant Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing MagVenture XP Orange Stimulator and active side of MagVenture COOL-B65 coil with Sham Comparator: Sham stimulation to either left IPL (50%) or left DLPFC (50%) for people with Treatment Resistant Depression. Participants receive MagVenture XP Orange Stimulator and active side of MagVenture COOL-B65 coil or Sham Comparator: Sham stimulation to either left IPL (50%) or left DLPFC (50%) and complete study visits and assessments.
Multiple locations, including Glostrup Municipality
This study is recruiting in the United States. It is testing cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicide prevention for treatment-resistant depression.
In San Diego
Why is this study shown?
This study is directly about Depression.
Depression, SuicidalityBehavioralFrom 18 Years to 70 Years
This study is looking at whether a digital support tool can help people with Treatment Resistant Depression or Ketamine. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether psychoeducation can help people with depression or Borderline Personality Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at use an established SV2A radiotracer produced at our Centre to determine the feasibility of integrating PET imaging in to psilocybin trials for people with Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Treatment resistant depression or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
